77 related articles for article (PubMed ID: 15523412)
21. Should sentinel lymph-node biopsy be used routinely for staging melanoma and breast cancers?
Scoggins CR; Chagpar AB; Martin RC; McMasters KM
Nat Clin Pract Oncol; 2005 Sep; 2(9):448-55. PubMed ID: 16265014
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
23. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
25. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
26. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cózar JM; Canton J; Tallada M; Concha A; Cabrera T; Garrido F; Ruiz-Cabello Osuna F
Cancer Immunol Immunother; 2005 Sep; 54(9):858-66. PubMed ID: 15887015
[TBL] [Abstract][Full Text] [Related]
27. Quantifying tumour-infiltrating lymphocyte subsets: a practical immuno-histochemical method.
Loughlin PM; Cooke TG; George WD; Gray AJ; Stott DI; Going JJ
J Immunol Methods; 2007 Apr; 321(1-2):32-40. PubMed ID: 17324439
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of sentinel lymph node biopsy in multifocal/multicentric breast cancer.
Lo YF; Cheung YC; Hsueh S; Ho KC
Chang Gung Med J; 2009; 32(1):51-8. PubMed ID: 19292939
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of interleukin-10 in sentinel lymph node with breast cancer.
Woo SU; Bae JW; Yang JH; Kim JH; Nam SJ; Shin YK
Ann Surg Oncol; 2007 Nov; 14(11):3268-73. PubMed ID: 17762971
[TBL] [Abstract][Full Text] [Related]
30. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
[TBL] [Abstract][Full Text] [Related]
31. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
Nakamura R; Sakakibara M; Nagashima T; Sangai T; Arai M; Fujimori T; Takano S; Shida T; Nakatani Y; Miyazaki M
Eur J Cancer; 2009 Aug; 45(12):2123-31. PubMed ID: 19398324
[TBL] [Abstract][Full Text] [Related]
32. Role of re-operative sentinel lymph node biopsy in locally recurrent breast cancer.
Rozen WM; Chow Y; Murphy C
Breast J; 2007; 13(6):629-30. PubMed ID: 17983414
[No Abstract] [Full Text] [Related]
33. Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.
Verdegaal EM; Hoogstraten C; Sandel MH; Kuppen PJ; Brink AA; Claas FH; Gorsira MC; Graadt van Roggen JF; Osanto S
Cancer Immunol Immunother; 2007 May; 56(5):587-600. PubMed ID: 16924494
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
Rutgers EJ
J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
[TBL] [Abstract][Full Text] [Related]
35. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node in breast cancer.
James TA; Edge SB
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):53-8. PubMed ID: 16493261
[TBL] [Abstract][Full Text] [Related]
37. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
38. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
Cheung KJ; Tam W; Chuang E; Osborne MP
Breast J; 2007; 13(4):413-7. PubMed ID: 17593048
[TBL] [Abstract][Full Text] [Related]
39. The prognostic importance of isolated tumor cell clusters and micrometastases in sentinel lymph nodes.
Weaver DL
Cancer Invest; 2009 Feb; 27(2):121-8. PubMed ID: 19235583
[No Abstract] [Full Text] [Related]
40. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
